1. No category

Tuberculosis
Therapeutics Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016-2026
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Tuberculosis (or) TB is a chronic infectious disease which is caused by Mycobacterium
tuberculosis. Tuberculosis, also known as pulmonary tuberculosis, infects to any part of the
body majorly affects lungs. Extra pulmonary tuberculosis occurs when infection spreads
other than the lungs. The bacterial infection that spreads through lymph nodes, blood stream
to any organ in body. Tuberculosis is a contagious disease and transmitted from person to
person through microscopic droplets released into the air. Tuberculosis is mainly of two
types–latent tuberculosis and active tuberculosis. In latent TB condition, person infected with
the bacteria but it is inactive state and cause no symptoms. It isn't contagious. It is also called
inactive tuberculosis (or) TB. It can turn into active TB, so treatment is important for the
person with latent TB and to help control the spread of TB. Active Tuberculosis stage enable
bacteria spread to others. It can occur in initial stages after infection with the Mycobacterium
tuberculosis bacteria, or it might occur years later. Tuberculosis can be diagnosed through the
tuberculin skin test or blood test. The positive tuberculin test or blood test enable to detect
person infected with bacteria but it unable to detect latent tuberculosis infection.
Tuberculosis Therapeutics Market: Drivers and restraints
Increasing prevalence rate of tuberculosis provides the lucrative market for the global
tuberculosis therapeutics market. According to the World Health Organization (WHO), about
one-third of the world’s population diagnosed with latent tuberculosis (TB), 9.6 million
people diagnosed with tuberculosis in 2014. 1 million children diagnosed and 0.14 million
children died in 2014. Low income and middle income countries more prevalent to the
tuberculosis. People infected with HIV are 20-30 times more likely to develop active
tuberculosis. The risk to occurrence active TB greater in persons suffering from other.
Report
Description
Report Description
conditions that impair the immune system. Program to treat tuberculosis ‘Directly Observed
Treatment, Short Course’ (DOTS) developed by WHO, witnessed robust growth of global
tuberculosis therapeutics market. Shortage of anti-tubercular drugs to treat TB in children
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/repgb-1303
Tuberculosis Therapeutics Market: Segmentation
Global Tuberculosis Therapeutics Market can be segmented as following types
•By Product:
•Hydrazine derivatives
•Isoniazid
•Miscellaneous anti tubercular drugs
•Rifampin
•Ethambutol
•Pyrazinamide
By End user:
•Hospital Pharmacies
Report
Description
Report Description
•Ambulatory Surgical Centers
•Individual Pharmacies
Tuberculosis Therapeutics Market: Overview
Increasing demand for advance medication to treat tuberculosis and rising awareness among
people and novel medications to treat the tuberculosis is expected to account for a robust
growth of global tuberculosis therapeutics market over the forecasted period.
Tuberculosis Therapeutics Market: Region-Wise Outlook
Depending upon the geographic regions tuberculosis therapeutics market segmented into
seven key regions: Those are North America, Latin America, and Eastern Europe, Western
Europe, and Asia pacific excluding japan, Japan, Middle East and Africa.
North America and Latin America regions is expected to dominate the tuberculosis
therapeutics market throughout the forecast period. People are becoming health conscious
and aware of treatments of tuberculosis in the region. Asian Pacific region and MEA are
anticipated to register double digit CAGR over the forecasted period.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1303
Tuberculosis Therapeutics Market: Key players
Some of the key players in Tuberculosis therapeutics market are Sigma Pharmaceutical Pty
Limited, Aventis Pharmaceuticals Limited, Novartis AG, Sanofi -aventis U.S LLC, Hoffmann-La
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705